低温等离子手术治疗早期喉癌整体预后及复发相关因素研究
DOI:
作者:
作者单位:

南京医科大学第一附属医院 江苏省人民医院耳鼻咽喉科南京,210029

作者简介:

通讯作者:

基金项目:

早期喉癌术后一期置入喉硅胶膜的临床研究,编号JSPH-MC-2021-22


Prognostic and relapsing factors of early laryngeal cancer treated by low-temperature? coblation
Author:
Affiliation:

The First Affiliated Hospital, Nanjing Medical University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的:探讨低温等离子手术对于早期喉癌治疗的预后情况,并评估相关风险因素对患者DFS的影响,从而分析影响手术疗效的因素,总结临床经验。 方法:回顾性分析2013-04至2020-12在我院接受经口内镜下低温等离子手术治疗的376例早期喉癌患者的临床资料,剔除了失访患者7例,总共收集了369例患者的资料。随访时间为32~124个月,中位随访时间72个月。并统计分析获得患者各项肿瘤学结果,包括DFS、OS、LC、LP。 结果:术后共计70例患者出现复发,40例死亡。所有患者总的1年、2年、5年DFS分别为89%(95%CI,86%-92%)、85%(82%-89%)、80%(76%-84%),中位DFS未到达。1年、2年、5年总生存期 OS分别为97%(95%CI,96%-99%)、92%(89%-95%)、89%(85%-92%),中位OS未到达。且ACI显著影响患者DFS,但对OS没有影响。而ACI患者1年、2年、5年DFS分别为87%(82%-92%)、82%(77%-88%)、76%(70%-82%)。而未侵犯患者1年、2年、5年DFS分别为92%(87%-96%),89%(84%-93%),85%(79%-91%)。 结论:等离子手术与CO2激光手术或是单纯放疗的疗效较为接近。ACI与术后肿瘤切缘也是影响患者术后DFS的重要因素,并且术后复发患者的二次等离子手术并非禁忌。术前做好相应评估,在确认前联合区域外侧甲状软骨没有明显侵犯并且术前判断可以获得阴性切缘的情况下再考虑行等离子手术治疗,才能使患者获得最佳疗效。

    Abstract:

    Objective: To investigate the prognosis of low-temperature plasma coblation for early laryngeal cancer, and to evaluate the influence of related risk factors on DFS of patients, so as to analyze the factors affecting the surgical effect and summarize clinical experience. Methods: The clinical data of 376 patients with early laryngeal cancer who received endoscopic low temperature plasma coblation in our hospital from April 2013 to December 2020 were retrospectively analyzed. 7 patients who were lost to follow-up were excluded, and a total of 369 patients were collected. The follow-up period ranged from 32 to 124 months, with a median follow-up of 72 months. Statistical analysis was performed to obtain various oncology results, including DFS, OS, LC and LP. Results: A total of 70 patients recurred and 40 died. Overall 1-year, 2-year, and 5-year DFS for all patients were 89% (95%CI, 86%-92%), 85% (82-89%), and 80% (76%-84%), respectively, and the median DFS was not reached. The 1-year, 2-year, and 5-year overall survival OS were 97% (95%CI, 96% to 99%), 92% (89% to 95%), and 89% (85% to 92%), respectively, with the median OS not reached. ACI significantly affected DFS, but had no effect on OS. The 1-year, 2-year and 5-year DFS of ACI patients were 87% (82-92%), 82% (777-88%) and 76% (70%-82%), respectively. In non-invasive patients, 1-year, 2-year and 5-year DFS were 92% (87%-96%), 89% (84%-93%) and 85% (79%-91%), respectively. Conclusion: The efficacy of plasma coblation is comparable to that of CO2 laser surgery or radiotherapy alone. Additionally, factors such as ACI and postoperative tumor margin play a significant role in determining postoperative DFS in patients. It should be noted that secondary plasma coblation is not contraindicated for patients with postoperative recurrence. Therefore, preoperative evaluation must be conducted accordingly, and plasma coblation should only be considered when there is confirmed absence of obvious invasion of the lateral thyroid cartilage in the anterior commissuret area and attainment of a negative incisal margin before surgery, ensuring optimal therapeutic outcomes for patients.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2024-01-28
  • 最后修改日期:2024-04-21
  • 录用日期:2024-04-24
  • 在线发布日期:
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭